Trial · NCT00488982
Results by group13
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 13 of 13
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Time to Progression | Docetaxel and Observation | 1.5 | 95% Confidence Interval 1.5 to 2.4 | months | |
| Time to Progression | Docetaxel and GM-CSF | 3.3 | 95% Confidence Interval 2.4 to 3.5 | months | |
| Overall Survival | Docetaxel and Observation | 14 | 95% Confidence Interval 10.5 to 27.6 | months | |
| Overall Survival | Docetaxel and GM-CSF | 28.4 | 95% Confidence Interval 19.2 to 34.1 | months | |
| Overall Survival | Overall Survival | 15.6 | 95% Confidence Interval 13.1 to 18.8 | months | |
| Number of Participants With PSA Response to Successive Series of Chemotherapy | Docetaxel and Observation | PSA response to Course 2 chemotherapy | 4 | Participants | |
| Number of Participants With PSA Response to Successive Series of Chemotherapy | Docetaxel and GM-CSF | PSA response to Course 2 chemotherapy | 8 | Participants | |
| Number of Participants With PSA Response to Successive Series of Chemotherapy | Docetaxel and Observation | PSA response to Course 3 chemotherapy | 1 | Participants | |
| Number of Participants With PSA Response to Successive Series of Chemotherapy | Docetaxel and GM-CSF | PSA response to Course 3 chemotherapy | 0 | Participants | |
| Cumulative Duration of Time on and Off Docetaxel-based Therapy | Docetaxel and Observation OFF Chemotherapy | 24.7 | 95% Confidence Interval 0.8 to 50.8 | months | |
| Cumulative Duration of Time on and Off Docetaxel-based Therapy | Docetaxel and GM-CSF OFF Chemotherapy | 30.9 | 95% Confidence Interval 1.7 to 77.1 | months | |
| Cumulative Duration of Time on and Off Docetaxel-based Therapy | Docetaxel + Observation ON Chemotherapy | 8.3 | 95% Confidence Interval 3.9 to 22.8 | months | |
| Cumulative Duration of Time on and Off Docetaxel-based Therapy | Docetaxel and GM-CSF ON Chemotherapy | 7.6 | 95% Confidence Interval 1.9 to 19.2 | months |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00488982/results